Breaking News
January 19, 2019 - Formlabs 3D prints anatomical models
January 19, 2019 - Heart-Healthy Living Also Wards Off Type 2 Diabetes
January 19, 2019 - Teaching Kids to Be Smart About Social Media (for Parents)
January 19, 2019 - Metabolite produced by gut microbiota from pomegranates reduces inflammatory bowel disease
January 19, 2019 - Researchers examine how spray from showers and toilets expose us to disease causing bacteria
January 19, 2019 - Behavioral experiments confirm that additional neurons improve brain function
January 19, 2019 - New study compares performance of real-time infectious disease forecasting models
January 19, 2019 - Obesity can be risk factor for developing renal cell carcinoma, confirms study
January 19, 2019 - New regulation designs on cigarette packs direct smokers’ attention to health warnings
January 19, 2019 - QIAGEN receives first companion diagnostic approval in Japan
January 19, 2019 - Study explores role of Dunning-Kruger effect in anti-vaccine attitudes
January 19, 2019 - Newly identified subset of immune cells may be key to fighting chronic inflammation
January 19, 2019 - New immune response regulators discovered
January 18, 2019 - Poor blood oxygenation during sleep predicts chance of heart-related death
January 18, 2019 - First international consensus on the diagnosis and management of fibromuscular dysplasia
January 18, 2019 - Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
January 18, 2019 - Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
January 18, 2019 - Scientists advise caution in immunotherapy research
January 18, 2019 - How children across the world develop language
January 18, 2019 - Columbia Medical Student Receives McDonogh Scholarship
January 18, 2019 - Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
January 18, 2019 - Plant based diet could be the best option for the planet says commission
January 18, 2019 - New conservation practice could reduce nitrogen from agricultural drainage, study shows
January 18, 2019 - UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit
January 18, 2019 - New study determines the fate of DNA derived from genetically modified food
January 18, 2019 - Scientists develop new gene therapy that prevents axon destruction in mice
January 18, 2019 - Study finds critically low HPV vaccination rates among younger adolescents in the U.S.
January 18, 2019 - Brain cells involved in memory play key role in reducing future eating behavior
January 18, 2019 - Risk for Conversion of MS Varies With Different Therapies
January 18, 2019 - Investigational cream may help patients with inflammatory skin disease
January 18, 2019 - Medical school news office receives six writing awards | News Center
January 18, 2019 - County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
January 18, 2019 - Research reveals risk for developing more than one mental health disorder
January 18, 2019 - Scientists discover a dramatic pattern of bone growth in female mice
January 18, 2019 - Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
January 18, 2019 - New nuclear medicine method could improve detection of primary and metastatic melanoma
January 18, 2019 - Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
January 18, 2019 - Health Tip: Don’t Ignore Changes in Skin Color
January 18, 2019 - Dietary Recommendations for Healthy Children
January 18, 2019 - Eliminating the latent reservoir of HIV
January 18, 2019 - Pain From The Government Shutdown Spreads. This Time It’s Food Stamps
January 18, 2019 - Newly discovered regulatory mechanism helps control fat metabolism
January 18, 2019 - New rapid blood tests could speed up TB diagnosis, save the NHS money
January 18, 2019 - Researchers develop intelligent system for ‘tuning’ powered prosthetic knees
January 18, 2019 - Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma
January 18, 2019 - New research detects mosquito known to transmit malaria for the first time in Ethiopia
January 18, 2019 - New guidelines to make swallowing safer for people in Australian nursing homes
January 18, 2019 - Lumex Instruments’ RA-915AM monitor installed at Hg treatment plant in Almadén, Spain
January 18, 2019 - ACCC survey finds multiple threats to growth of cancer programs
January 18, 2019 - Meeting the challenge of engaging men in HIV prevention and treatment
January 18, 2019 - Furloughed Feds’ Health Coverage Intact, But Shutdown Still Complicates Things
January 18, 2019 - Experts discuss various aspects on health risks posed by fumigated containers
January 18, 2019 - Researchers use gene-editing tool CRISPR/Cas9 to limit impact of parasitic diseases
January 18, 2019 - Alpha neurofeedback training could be a means of enhancing learning success
January 18, 2019 - Innovative ‘light’ method demonstrates positive results in fight against malignant tumors
January 18, 2019 - The cytoskeleton of neurons found to play role in Alzheimer’s disease
January 18, 2019 - New resource-based approach to improve HIV care in low- and middle-income countries
January 18, 2019 - Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board
January 18, 2019 - New study shows link between secondhand smoke and cardiac arrhythmia
January 18, 2019 - DZIF scientists reveal problems with available diagnostics for Zika and chikungunya virus
January 18, 2019 - Breast cancers more likely to metastasize in young women within 10 years of giving birth
January 18, 2019 - Over 5.6 million Americans exposed to high nitrate levels in drinking water
January 18, 2019 - Blood vessels can now be created perfectly in a petri dish
January 18, 2019 - Study identifies prominent socioeconomic and racial disparities in health behavior in Indiana
January 18, 2019 - Young-Onset Type 2 Diabetes Tied to Increased Hospitalization Risk
January 18, 2019 - For-profit nursing schools associated with lower performance on nurse licensure test
January 18, 2019 - Considering the culture of consent in medicine
January 18, 2019 - Researchers identify comprehensive guidelines for managing severe atopic dermatitis
January 18, 2019 - Analyzing proteins in blister fluid may classify burn severity more accurately
January 18, 2019 - Study finds higher suicide rates among youth who were Medicaid enrollees
January 18, 2019 - Opioid drugs often overprescribed to children for pain relief, say CHOP surgeons
January 18, 2019 - New biodegradable wound dressing material accelerates healing
January 18, 2019 - Life in Space May Take Toll on Spinal Muscles
January 18, 2019 - Bulldogs’ screw tails linked to human genetic disease
January 18, 2019 - Immunotherapy target identified for pediatric cancers
January 18, 2019 - Financial stress may increase heart disease risk in African Americans
January 18, 2019 - Scientists solve another piece of Ebola virus puzzle
January 18, 2019 - New project finds how endocrine disruptors interfere with thyroid functions
January 18, 2019 - Research finds decline in ketone body utilization when coronary circulation is reduced
January 18, 2019 - Let’s map our DNA and save billions each year in health costs
Barrow Institute initiates $50 million effort to seek cure for glioblastoma

Barrow Institute initiates $50 million effort to seek cure for glioblastoma

image_pdfDownload PDFimage_print

Barrow Neurological Institute has initiated a $50 million effort, supported by the single largest research grant in the history of brain tumor research, to seek a cure for the deadliest form of brain cancer. Funding from The Ben and Catherine Ivy Foundation will be used to dramatically accelerate drug discovery and clinical testing for glioblastoma in the newly-formed Ivy Brain Tumor Center at the Barrow Neurological Institute.

The Ivy Center will become a cornerstone at Barrow, which conducts more brain tumor operations than any hospital in the nation, and is part of Dignity Health St. Joseph’s Hospital and Medical Center. Already screening malignant brain tumor patients from around the world, the new Center will ultimately mean that every patient, regardless of diagnosis or state of the tumor, will have the individualized option for an experimental therapy.

“This grant will fast track discovery and offer support and hope to those battling glioblastoma and other malignant brain tumors,” says Nader Sanai, MD, director of neurosurgical oncology. Dr. Sanai is an internationally renowned pioneer in glioblastoma research and will head the new Center. “The formation of the Ivy Brain Tumor Center will propel our singular research strategy to a new level of personalized medicine as we put a laser focus on discovering a cure,” he said. “The Ivy Foundation’s commitment is a true gift of hope.”

Catherine Ivy, president of The Ben and Catherine Ivy Foundation, said the Center’s ultimate goal is to cure brain cancer. “The more we discover, the more we can do to help patients and their families. Our Foundation has partnered with renowned medical and research programs throughout the United States and even internationally,” she said. “After years of assessment, we have decided to invest in the Ivy Brain Tumor Center at Barrow. We think Barrow and the new Ivy Brain Tumor Center are our best bet. “

More than 138,000 Americans currently are living with a malignant brain tumor and more than nine out of 10 diagnosed with glioblastoma die within five years. Market forces and a string of high-profile clinical trial failures have led pharmaceutical firms to de-prioritize malignant brain tumor patients. Between 1998 and 2014, 78 investigational brain tumor drugs entered advanced clinical trial evaluation and 75 failed.

This lack of new drugs led Dr. Sanai in 2016 to launch a bold approach to treat glioblastoma with Barrow’s ‘Phase 0’ trials. In a Phase 0 trial, a patient receives a small dose of an experimental drug the day before surgery. During the operation, surgeons collect the patient’s samples and a team of scientists immediately test for the effectiveness of the drug. Results are available in days and, if the trial drug proves to be active, the patient goes on to receive aggressive treatment with higher doses. This approach is a unique form of personalized medicine and the first of its kind for brain tumor patients.

Prior to Barrow’s daring expansion into Phase 0 trialing, complex studies like this were only attempted at the National Institutes of Health. Now, Barrow is leading a national movement to rapidly identify new drugs that will save lives. “Phase 0 trials are the quickest route to identify individualized strategies for treating glioblastoma and our approach demands only a fraction of the time and costs associated with traditional drug research and development,” says Dr. Sanai. “With the Ivy Foundation’s grant and Barrow’s expertise in Phase 0 trialing, we believe glioblastoma will meet its match.”

The Ben and Catherine Ivy Foundation, based in Scottsdale, Ariz., is the largest non-governmental funding mechanism of brain tumor research in the world, having committed more than $123 million to patient-focused research on gliomas, a type of tumor that occurs in the brain and spinal cord. Ivy became involved in brain tumor research when her husband, Ben, lost his battle with glioblastoma in 2005.

“Thanks to the Ivy Foundation’s inspiring commitment, the Barrow Neurological Institute has established the Ivy Brain Tumor Center, a 15,000 square foot state-of-the-art facility that provides Dr. Sanai and his team of scientists and clinician specialists with state-of-the-art resources to focus on accelerated patient trials and save lives”, said Katie Cobb, president of the Barrow Neurological Foundation.

Source:

https://www.barrowneuro.org/

Tagged with:

About author

Related Articles